BioSpace News Archive

Biotech Beach

Medical Breakthrough in Parkinson’s Disease Diagnostics Attained by Global WholeHealth Partners, Corp (OTC: GWHP) as Leading Researcher Believes a Parkinson’s Epidemic is on the Horizon

Global WholeHealth Partners Corp (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests, attains breakthrough on rising neurological disease.

April 13, 2021
·
5 min read
Genetown

Adagio Therapeutics Initiates Global Clinical Trial of ADG20 as a Treatment for COVID-19

Phase 1/2/3 STAMP Trial to be Conducted Globally, Including in Countries with High Rates of SARS-CoV-2 Variants Resistant to Other Monoclonal Antibody Products

April 13, 2021
·
6 min read
Policy

PREXA SANTÉ Announces Positive Top-line Human Clinical Trial Results Of Treatment for COVID-19Company Receives FDA Guidance thru Pre-IND response

PREXA SANTÉ announced positive top-line results from a human clinical trial of Product-118, the company’s proprietary combination medical device/drug treatment for COVID-19.

April 13, 2021
·
2 min read
Business

TeamedOn and AGTC Announce a Licensing Agreement Advancing X-Linked Retinoschisis Gene Therapy Program

TeamedOn International, Inc. and Applied Genetic Technologies Corporation announced a licensing agreement to advance gene therapy to treat X-linked retinoschisis, an inherited disease that causes loss of vision due to degeneration of the retina in males.

April 13, 2021
·
6 min read
Pharm Country

Tiziana Life Sciences plc Announces Plans to List Accustem Sciences Limited in the U.S.

Tiziana Life Sciences plc, announced that its former subsidiary, Accustem Sciences Limited, intends to file a listing application with the Nasdaq Stock Market shortly after completion of the distribution of shares in Accustem to Tiziana Life Sciences plc shareholders.

April 13, 2021
·
2 min read
Drug Development

MEI Pharma and Kyowa Kirin Announce Completion of Patient Enrollment in Follicular Lymphoma Primary Efficacy Population of Global Phase 2 TIDAL Study Intended to Support Potential Accelerated Approval Application from U.S. FDA

MEI Pharma, Inc. and Kyowa Kirin Co., Ltd. announced completion of enrollment in the follicular lymphoma primary efficacy population of the global Phase 2 TIDAL study.

April 13, 2021
·
8 min read
Genetown

Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors

Theseus Pharmaceuticals, a biotechnology company shaping the future of targeted oncology by developing best-in-class, pan-variant kinase inhibitors, emerged from stealth today announcing the close of a $100 million Series B financing led by Foresite Capital.

April 13, 2021
·
5 min read
Drug Development

Peptilogics Announces Successful Completion of Phase 1 Clinical Trial of PLG0206, a First-in-Class Anti-Infective Peptide Therapy

Peptilogics, a biotechnology platform company leveraging computational design to discover novel peptide therapeutics, today announced the completion of a Phase 1 clinical trial for its lead compound PLG0206

April 13, 2021
·
4 min read
Pharm Country

Biohaven Highlights Neuroscience Advancements with 22 Presentations at the 2021 American Academy of Neurology (AAN) Virtual Annual Meeting

- Pivotal trial of rimegepant for the preventive treatment of migraine spotlights reduction of 4.3 monthly migraine days during weeks 9-12 and rapid onset of preventive effects observed within the first week of treatment - Post-hoc analysis of rimegepant in the acute treatment of migraine dosed on an as needed (p.r.n.) basis demonstrated clinically relevant reductions in monthly migraine days over time

April 13, 2021
·
13 min read
Drug Development

Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer

Pre-specified interim analysis concluded with favorable recommendation to continue the LUNAR trial DMC stated accrual to 534 patients is likely unnecessary and possibly unethical for patients randomized to control arm and recommended a shortened trial

April 13, 2021
·
10 min read